Abstract
Hypertension is one of the leading risk factors for cardiovascular disease, myocardial infarction, and stroke. There are gender differences in the prevalence of hypertension and in the mechanisms responsible for hypertension in humans. This review will discuss the mechanisms for regulation of blood pressure, sex differences that have been identified in animal studies, and the gender differences that have been identified in humans.
Art work by Piet Michiels, Leuven, Belgium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander BT, Cockrell KL, Rinewalt AN, Herrington JN, Granger JP. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1388–92.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen O, Legro R, Normal R, Taylor A, Witchel S. Position statement: criteria for defining polycystic ovary syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237–5.
Baba T, Endo T, Honnma H, et al. Association between polycystic ovary syndrome and female-to male transsexuality. Hum Reprod. 2006;22:1011–6.
Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of BP during sleep. Hypertension. 2007;49:235–1241.
Chappell MC. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol. 2016;310:H137–52.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. National Heart, Lung, and Blood Institute joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:256072.
Christakou C, Economou F, Livadas S, Piperi C, Adamopoulos C, Marinakis E, Jdiamanti-Kandarakis E. Strong and Positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones (Athens). 2011;10:292–7.
da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension. 2008;51:884–90.
Dalmasso C, Maranon R, Patil C, Moulana M, Romero DG, Reckelhoff JF. 20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats. Am J Physiol Renal Physiol. 2016;311:F71–7.
Davis DD, Ruiz AL, Yanes LL, Iliescu R, Yuan K, Moulana M, Racusen LL, Reckelhoff JF. Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension. 2012;59:726–31.
de Kraker AT, Kenemans P, Smolders RG, Kroeks MV, van der Mooren MJ. Short-term effects of continuous combined oestrogenprogestogen therapy on several cardiovascular risk markers in healthy postmenopausal women; a randomized control trial. Eur J Obstet Gynecol Reprod Biol. 2009;142:139–44.
Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, Mosely J, Martin JN Jr, Dechend R, La Marca B. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2012;303:R353–8.
Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Exp Rev Molec Med. 2008;10:1–21.
do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, Perez de Lara CE, Hall JE. Role of the brain melanocortins in blood pressure regulation. Biochim Biophys Acta. 2017;1863(10 Pt A):2508–14.
Escobar-Morreale HF, San Millan JL. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinol Metab. 2007;18:266–72.
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Comparative risk assessment collaborating group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:134760.
Fortepiani LA, Reckelhoff JF. Treatment with tetrahydrobiopterin reduces blood pressure in male SHR by reducing testosterone synthesis. Am J Physiol Regul Integr Comp Physiol. 2005a;R288:R733–6.
Fortepiani LA, Reckelhoff JF. Increasing oxidative stress with molsidomine increases blood pressure in genetically hypertensive rats but not normotensive controls. Am J Physiol Regul Integr Comp Physiol. 2005b;289:R763–70.
Fortepiani LA, Reckelhoff JF. Role of oxidative stress in the sex differences in blood pressure in spontaneously hypertensive rats. J Hypertens. 2005c;23:801–5.
Gohar EY, Giachini FR, Pollock DM, Tostes RC. Role of endothelin system in sexual dimorphism in cardiovasular and renal diseaes. Life Sci. 2016;159:20–9.
Gu A, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control am19 US adults with hypertension: data from the national health and examination survey 19992004. Am J Hypertens. 2008;21:78998.
Hall JE, Guyton AC, Brands MW. Control of sodium excretion and arterial pressure by intrarenal mechanisms and the renin-angiotensin system. In: Laragh JH, Brenner BM, editors. Hypertension, pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 1452–75.
Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kidney Int Suppl. 1996;55:S35–41.
Health, United States. National Center for Health Statistics. With special feature on death abd dying. Hyattsville, MD 2011. Table 67 Hypertension and high blood pressure among persons 20 years of age and over, by selected characteristics: US, selected years 1988–1994 through 2005-2008, 2010. p. 250–51.
Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006;17(Suppl 3):S218–25.
Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the women’s health initiative. Circulation. 2007;115:85560.
Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K. Effects of long term transdermal hormone replacement therapy on the renin-angiotensin-aldosterone system, plasma bradykinin levels and BP in normotensive postmenopausal women. Geriatr Gerontol Int. 2008;8:259–64.
Iliescu R, Yanes LL, Bell W, Dwyer T, Baltatu OC, Reckelhoff JF. Role of the renal nerves in blood pressure in male and female SHR. Am J Physiol Regul Integr Comp Physiol. 2006;290:R341–4.
Issa Z, Seely EW, Rahme M, El-Hajj Fuleihan G. Effects of hormone therapy on blood pressure. Menopause. 2015;22:456–68.
Kim JK, Alley D, Seeman T, Karlamangla A, Crimmins E. Recent changes in cardiovascular risk factors among women and men. J Women’s Health (Larchmont). 2006;15:73446.
Komatsumoto S, Nara M. Changes in the level of endothelin-1 with aging. Nippon Ronen Igakkai Zasshi. 1995;32:664–9.
Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet. 2002;360:190313.
Lima R, Yanes LL, Davis DD, Reckelhoff JF. Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2013;304:R248–51.
Ljungman C, Kahan T, Schiöler L, Hjerpe P, Hasselström J, Wettermark B, Boström KB, Manhem K. Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD). J Am Soc Hypertens. 2014;8:882–90.
Lopez-Ruiz AF, Iliescu R, Reckelhoff JF. Refractory blood pressure in female SHR to increased oxidative stress is not mediated by NO or by upregulation of renal antioxidant enzymes. Am J Physiol Regul Integr Comp Physiol. 2010;298:R266–71.
Mannerås L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148:3781–91.
Maranon RO, Reckelhoff JF. Mechanisms responsible for postmenopausal hypertension in a rat model: Roles of the renal sympathetic nervous system and the renin-angiotensin system. Physiol Rep. 2016;4:e12669.
Maranon RO, Lima R, Mathbout M, Do Carmo JM, Hall JE, Roman RJ, Reckelhoff JF. Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. Am J Physiol Regul Integr Comp Physiol. 2014;306:R248–56.
Maranon R, Lima R, Spradley FT, do Carmo JM, Zhang H, Smith AD, Bui E, Thomas RL, Moulana M, Hall JE, Granger JP, Reckelhoff JF. Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats. Am J Physiol Regul Integr Comp Physiol. 2015;308:R708–13.
Mathis KW, Venegas-Pont M, Masterson CW, Stewart NJ, Wasson KL, Ryan MJ. Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus. Hypertension. 2012;59:673–9.
Mosca L, Banka CL, Benjamin EJ, Berr K, Bushnell C, Ganiats T, et al. Update: American Heart Association evidence-based guidelines for cardiovascular disease 2007 update. Circulation. 2007;115:1481–501.
Nautiyal M, Shaltout HA, de Lima DC, do Nascimento K, Chappell MC, Diz DI. Central angiotensin-(1-7) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats. Hypertension. 2012;60:1257–65.
Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:6975.
Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;118:429–32.
Prelevic GM, Kwong P, Byrne DJ, Jagroop IA, Ginsburg J, Mikhailidis DPA. Cross-sectional study of the effect of hormone replacement therapy on cardiovascular disease risk profile in healthy postmenopausal women. Fertil Steril. 2002;77:945–51.
Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004;43:918–23.
Reckelhoff JF, Wofford M. Chapter 70: Hypertension in women. In: Rexrode K, Wickline M, editors. Women and health. 2nd ed. New York: Elsevier; 2012.
Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31:435–9.
Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension. 2000;35:480–3.
Rodriguez-Iturbe B, Pons H, Johsnon RJ. Role of the immune system in hypertension. Physiol Rev. 2017;97:1127–64.
Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131–85.
Romero JC, Reckelhoff JF. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999;34:943–9.
Routledge FS, McFetridge-Durdle JA, Stress DCR. Menopausal status and nocturnal BP dipping patterns among hypertensive women. Can J Cardiol. 2009;25:e157–63.
Sarganas G, Neuhauser HK. The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011. Hypertens Res. 2016;39:457–66.
Sartori-Valinotti JC, Iliescu R, Yanes LL, Dorsett-Martin W, Reckelhoff JF. Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked. Hypertension. 2008;51:1170–6.
Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59–64.
Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP. Multicenter AIDS cohort study. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005;19:953–60.
Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens. 2008;21:1152–6.
SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A randomized trial of intensive versus standard blood pressure control. N Engl J Med. 2015;373:2103–16.
Stepp DW, Osakwe CC, Belin de Chantemele EJ, Mintz JD. Vascular effects of deletion of melanocortin-4 receptors in rats. Physiol Rep. 2013;1:e00146.
Stolarz K, Staessen JA, O’Brien ET, Night-time BP. Dipping into the future? J Hypertension. 2002;21:2131–3.
Sullivan JC, Sasser JM, Pollock JS. Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2007;292:R764–8.
Swart R, van Rooyen JM, Mels CMC. Change in renin, cardiovascular and inflammatory markers over three years in black and white population: the SABPA Study. BMC Cardiovasc Disord. 2017;17:104.
Taylor EB, Ryan MJ. Immunosuppression with mycophenolate mofetil attenuates hypertension in an experimental model of autoimmune disease. J Am Heart Assoc. 2017;27:6.
Tipton AJ, Baban B, Sullivan JC. Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males. Am J Physiol Regul Integ Comp Physiol. 2012;303:R359–67.
Tyson CC, Coffman TM. In the wake of systolic blood pressure intervention trial: new targets for improving hypertension management in chronic kidney disease? Nephron. 2017;135:287–90.
Venegas-Pont M, Sartori-Valinotti JC, Glover PH, Reckelhoff JF, Ryan MJ. Sexual dimorphism in the blood pressure response to angiotensin II in mice after angiotensin converting enzyme blockade. Am J Hypertens. 2010;23:92–6.
Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 1994;91:5212–6.
Wenger NK, Ferdinand KC, Bairey Merz CN, Walsh MN, Gulati M, Pepine CJ. American College of Cardiology Cardiovascular Disease in women committee. Women, hypertension, and the systolic blood pressure intervention trial. Am J Med. 2016;29:1030–6.
Xue B, Pamidimukkala J, Hay M. Sex differences in the development of angiotensin II induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol. 2005;288:H2177–84.
Yanes LL, Romero DG, Cucchiarelli VE, Fortepiani LA, Gomez-Sanchez CE, Santacruz F, Reckelhoff JF. Role of endothelin in mediating postmenopausal hypertension in a rat model. Am J Physiol Regul Integr Comp Physiol. 2005a;288:R229–33.
Yanes L, Romero D, Iliescu R, Cucchiarelli VE, Fortepiani LA, Santacruz F, Bell W, Zhang H, Reckelhoff JF. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2005b;288:R903–8.
Yanes LL, Romero DG, Iles JW, Iliescu R, Gomez-Sanchez C, Reckelhoff JF. Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2006;291:R383–90.
Yanes LL, Lima R, Moulana M, Romero DG, Yuan K, Ryan MJ, Baker R, Zhang H, Fan F, Davis DD, Roman RJ, Reckelhoff JF. Postmenopausal hypertension: role of 20-HETE. Am J Physiol Regul Integr Comp Physiol. 2011a;300:R1543–8.
Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, Lockhart R, Racusen LC, Reckelhoff JF. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med. 2011b;8:103–15.
Yi X, Han Z, Zhou Q, Lin J, Liu P. 20-Hydroxyeicosatetraenoic acid as a predictor of neurological deterioration in acute minor ischemic stroke. Stroke. 2016a;47:3045–7.
Yi X, Wu L, Liao D, Wang C, Zhang B. Interactions among CYP2C8, EPHX2, and CYP4A11 variants and CYP plasma metabolite levels in ischemic stroke. J Atheroscler Thromb. 2016b;23:1286–93.
Zhang F, Chen CL, Qian JQ, Yan JT, Cianflone K, Xiao X, Wang DW. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. Cell Res. 2005;15:717–24.
Zimmerman MA, Harris RA, Sullivan JC. Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males. Am J Physiol Renal Physiol. 2014;306:F1136–42.
Zu L, Guo G, Zhou B, Gao W. Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome. Thromb Res. 2016;144:192–201.
Acknowledgments
This work is supported by NIH grants, R01HL66072, R01HL67028, P01HL51971, and P20GM121334.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Reckelhoff, J.F. (2018). Sex Differences in Regulation of Blood Pressure. In: Kerkhof, P., Miller, V. (eds) Sex-Specific Analysis of Cardiovascular Function. Advances in Experimental Medicine and Biology, vol 1065. Springer, Cham. https://doi.org/10.1007/978-3-319-77932-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-77932-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77931-7
Online ISBN: 978-3-319-77932-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)